QQQ   264.16 (-3.05%)
AAPL   107.12 (-4.19%)
MSFT   200.59 (-3.29%)
FB   249.02 (-2.25%)
GOOGL   1,409.39 (-3.45%)
AMZN   2,999.86 (-4.13%)
NVDA   484.95 (-4.07%)
TSLA   380.36 (-10.34%)
BABA   272.95 (-0.85%)
CGC   14.60 (-8.98%)
GE   6.11 (-2.24%)
MU   49.85 (+0.30%)
AMD   74.73 (-3.82%)
T   27.87 (-2.24%)
F   6.64 (-2.06%)
ACB   5.17 (-29.37%)
GILD   63.09 (-0.49%)
NFLX   470.61 (-4.19%)
DIS   123.28 (-3.09%)
BAC   23.26 (-2.84%)
BA   151.18 (-3.58%)
QQQ   264.16 (-3.05%)
AAPL   107.12 (-4.19%)
MSFT   200.59 (-3.29%)
FB   249.02 (-2.25%)
GOOGL   1,409.39 (-3.45%)
AMZN   2,999.86 (-4.13%)
NVDA   484.95 (-4.07%)
TSLA   380.36 (-10.34%)
BABA   272.95 (-0.85%)
CGC   14.60 (-8.98%)
GE   6.11 (-2.24%)
MU   49.85 (+0.30%)
AMD   74.73 (-3.82%)
T   27.87 (-2.24%)
F   6.64 (-2.06%)
ACB   5.17 (-29.37%)
GILD   63.09 (-0.49%)
NFLX   470.61 (-4.19%)
DIS   123.28 (-3.09%)
BAC   23.26 (-2.84%)
BA   151.18 (-3.58%)
QQQ   264.16 (-3.05%)
AAPL   107.12 (-4.19%)
MSFT   200.59 (-3.29%)
FB   249.02 (-2.25%)
GOOGL   1,409.39 (-3.45%)
AMZN   2,999.86 (-4.13%)
NVDA   484.95 (-4.07%)
TSLA   380.36 (-10.34%)
BABA   272.95 (-0.85%)
CGC   14.60 (-8.98%)
GE   6.11 (-2.24%)
MU   49.85 (+0.30%)
AMD   74.73 (-3.82%)
T   27.87 (-2.24%)
F   6.64 (-2.06%)
ACB   5.17 (-29.37%)
GILD   63.09 (-0.49%)
NFLX   470.61 (-4.19%)
DIS   123.28 (-3.09%)
BAC   23.26 (-2.84%)
BA   151.18 (-3.58%)
QQQ   264.16 (-3.05%)
AAPL   107.12 (-4.19%)
MSFT   200.59 (-3.29%)
FB   249.02 (-2.25%)
GOOGL   1,409.39 (-3.45%)
AMZN   2,999.86 (-4.13%)
NVDA   484.95 (-4.07%)
TSLA   380.36 (-10.34%)
BABA   272.95 (-0.85%)
CGC   14.60 (-8.98%)
GE   6.11 (-2.24%)
MU   49.85 (+0.30%)
AMD   74.73 (-3.82%)
T   27.87 (-2.24%)
F   6.64 (-2.06%)
ACB   5.17 (-29.37%)
GILD   63.09 (-0.49%)
NFLX   470.61 (-4.19%)
DIS   123.28 (-3.09%)
BAC   23.26 (-2.84%)
BA   151.18 (-3.58%)
Log in
OTCMKTS:EVTCY

Evotec Stock Forecast, Price & News

$53.20
+0.25 (+0.47 %)
(As of 09/23/2020 12:00 AM ET)
Add
Compare
Today's Range
$53.20
Now: $53.20
$53.20
50-Day Range
$51.35
MA: $53.01
$55.00
52-Week Range
$40.42
Now: $53.20
$59.91
Volume233 shs
Average Volume745 shs
Market Capitalization$4.03 billion
P/E Ratio140.00
Dividend YieldN/A
Beta0.98
Evotec AG provides drug discovery and development solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and not-for-profit organizations worldwide. The company operates in two segments, EVT Execute and EVT Innovate. The EVT Execute segment offers drug discovery services, such as target identification and validation, hit identification, sample management, chemistry, drug metabolism and pharmacokinetics, research informatics proteomics and metabolomics, bio-reagents, in vitro biology, in vivo pharmacology, biomarkers, and antibody platform; INDiGO, a program for accelerating the early drug candidates into the clinic stage; integrated chemistry, manufacturing, and control services; and integrated drug discovery services. The EVT Innovate segment is involved in investing and developing proprietary assets, including early-stage discovery programs, as well as advanced drug candidates in the areas of diabetes and diabetic complications, inflammatory diseases, neuroscience, oncology, and pain and anti-infective. Evotec AG has a strategic drug discovery and development partnership with Celgene Corporation; strategic research alliance with Novo Nordisk A/S; collaboration with Sanofi; research collaboration with Almirall; research alliance with Ferring Pharmaceuticals; strategic collaboration with Centogene; collaboration with Immuneering; and drug discovery alliance with LEO Pharma. The company was founded in 1993 and is headquartered in Hamburg, Germany.
Read More
Evotec logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.63 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:EVTCY
CUSIPN/A
CIKN/A
Phone49-4056-0810

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$500.07 million
Cash Flow$1.29 per share
Book Value$7.08 per share

Profitability

Net Income$42.64 million

Miscellaneous

Employees3,030
Market Cap$4.03 billion
Next Earnings Date11/10/2020 (Estimated)
OptionableNot Optionable
$53.20
+0.25 (+0.47 %)
(As of 09/23/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive EVTCY News and Ratings via Email

Sign-up to receive the latest news and ratings for EVTCY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Evotec (OTCMKTS:EVTCY) Frequently Asked Questions

How has Evotec's stock price been impacted by COVID-19?

Evotec's stock was trading at $49.10 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, EVTCY stock has increased by 8.4% and is now trading at $53.20.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Evotec?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Evotec in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Evotec
.

When is Evotec's next earnings date?

Evotec is scheduled to release its next quarterly earnings announcement on Tuesday, November 10th 2020.
View our earnings forecast for Evotec
.

How were Evotec's earnings last quarter?

Evotec AG (OTCMKTS:EVTCY) posted its quarterly earnings data on Wednesday, August, 12th. The company reported ($0.15) earnings per share for the quarter. The company had revenue of $122.85 million for the quarter. Evotec had a net margin of 7.06% and a return on equity of 6.95%.
View Evotec's earnings history
.

Who are some of Evotec's key competitors?

Who are Evotec's key executives?

Evotec's management team includes the following people:
  • Dr. Werner Lanthaler, CEO & Member of Management Board (Age 51)
  • Mr. Enno Spillner, CFO & Member of Management Board (Age 49)
  • Dr. Cord Dohrmann, Chief Scientific Officer & Member of Management Board (Age 55)
  • Dr. Craig Johnstone, COO & Member of Management Board
  • Ms. Anja Bosler, Principal Accounting Officer and Sr. VP of Group Accounting

What is Evotec's stock symbol?

Evotec trades on the OTCMKTS under the ticker symbol "EVTCY."

How do I buy shares of Evotec?

Shares of EVTCY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Evotec's stock price today?

One share of EVTCY stock can currently be purchased for approximately $53.20.

How big of a company is Evotec?

Evotec has a market capitalization of $4.03 billion and generates $500.07 million in revenue each year. The company earns $42.64 million in net income (profit) each year or $0.56 on an earnings per share basis. Evotec employs 3,030 workers across the globe.

What is Evotec's official website?

The official website for Evotec is www.evotec.com.

How can I contact Evotec?

Evotec's mailing address is Manfred Eigen Campus Essener Bogen 7, Hamburg 2M, 22419. The company can be reached via phone at 49-4056-0810 or via email at [email protected]

This page was last updated on 9/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.